Other country trade disputes
Vietnam cables: Data exclusivity should be automatic, comprehensive, retroactive and without procedures and formalities
Submitted by James Love on 15. September 2011 - 3:55 |
| Michael W. Michalak, former Ambassador to Vietnam, pressured Vietnam on behalf of PhRMA. |
Cables recently published by Wikileaks illustrate the degree to which the U.S. has been engaged in writing laws and training judges and government officials in Vietnam, on a wide range of pharmaceutical and intellectual property issues.
Dominican Republic: December 2009 meeting between PhRMA and US Embassy to discuss CAFTA+ demands on patent protection
September 10, 2011
KEI Staff
 |
| Christopher Lambert was Deputy Chief of Mission for the United States Embassy in Santo Domingo |
This is a cable written by Christopher Lambert, then the Deputy Chief of Mission for the United States Embassy in Santo Domingo, the capital of the Dominican Republic.
France gets an A+ from the US for its anti-consumer intellectual property related policies
Submitted by Manon Ress on 8. September 2011 - 12:33 |
| Hillary Clinton and Nicolas Sarkozy, March 14, 2011 |
 |
| President Obama and Mark Pekala, June 6, 2009, Paris |
France gets an A+ from the US for its anti consumer intellectual property related policies
Cables that mention Novartis
Submitted by James Love on 8. September 2011 - 12:20September 6, 2011
KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
Feb 28, 2003 | Turkey | Consulate Istanbul | Differences Among U.s. Firms Give Rise To New Association Of Research-based Pharmaceutical Companies
Cable: US Government collaboration with drug companies to lobby the Finnish Parliament on drug pricing legislation
Submitted by James Love on 6. September 2011 - 0:00This July 9, 2008 cable concerns the collaboration between the US government and the pharmaceutical industry to lobby Finland on the pricing of pharmaceutical drugs. The cable was written by Michael A Butler, then the Deputy Chief of Mission in Helsinki, and is worth a read. Among other things, the cable says :
 |
New Zealand measures to prevent parallel trade in medicine from NZ to US
Submitted by James Love on 4. September 2011 - 9:53Wikileaks has published 28 cables, dated July 13, 2004 to February 9, 2010, from the US Embassy in Wellington, New Zealand that mention pharmaceuticals (See list here: http://keionline.org/node/1231)
One of the cables discusses in detail the efforts of the New Zealand government to prevent pharmaceutical products that are sold in New Zealand from being parallel traded into the U.S. market. There are several interesting points made in the cable. Here are a few highlights:
Cables on New Zealand and pharmaceutical drugs
September 2, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
The following are 28 cables sent from the US Embassy in Wellington, New Zealand, that mention pharmaceuticals, from July 13, 2004 to February 9, 2010.
07/13/04 | New Zealand-australia Regulatory Agency To Raise Industry's Costs
Cables on Poland Reimbursements for pharmaceutical drugs
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
The US Department of States has been deeply involved in pushing the Poland government to provide more industry favorable rules for setting reimbursements for pharmaceutical drugs. Below are links to discussions of some of the cables published in 2011 by Wikileaks:
2008 May 14 Cable: Poland wants to cap drug cost effectiveness at 3x GDP/pop. Pfizer wants 6x
September 3, 2011
From KEI staff review of Wikileaks cables (http://keionline.org/wikileaks)
On May 14, 2008, The US Embassy in Warsaw sent a cable that discussed additions to the list of pharmaceutical products reimbursed by the government.
A few highlights from this cable:
KEI RN 2007:2 Recent examples of compulsory licensing of patents
KEI Research Note 2007:2 [1]
(A PDF version of this is available here.)
Recent examples of the use of compulsory licenses on patents[1]
KEI Research Note 2007:2
